Coding microsatellite instability analysis in microsatellite unstable small intestinal adenocarcinomas identifies MARCKS as a common target of inactivation

Molecular Carcinogenesis

Volumn 49, Issue 2, 2010, Pages 175-182

  Michel, Sara ^a,b   Kloor, Matthias ^a,b   Singh, Sandhya ^a   Gdynia, Georg ^a   Roth, Wilfried ^a   Von Knebel Doeberitz, Magnus ^a,b   Schirmacher, Peter ^a   Bläker, Hendrik ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Coding microsatellites; DNA mismatch repair; MARCKS; Microsatellite instability; Small intestinal carcinoma

Indexed keywords

MARCKS PROTEIN;

ACVR2 GENE; ADULT; AGED; AIM2 GENE; ALLELE; ARTICLE; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; GENE; GENE FREQUENCY; GENE MUTATION; HUMAN; HUMAN TISSUE; INTESTINE CARCINOMA; INTESTINE CRYPT; INTESTINE VILLUS; MARCKS GENE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MUTATION RATE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TGFBETAR2 GENE;

ADENOCARCINOMA; DNA METHYLATION; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL NEOPLASMS; INTESTINE, SMALL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICROSATELLITE REPEATS; MUTATION; PROMOTER REGIONS, GENETIC;

EID: 75849130566     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20587     Document Type: Article

References (43)

1. Hibi K, Kondo K, Akiyama S, Ito K, Takagi H. Frequent genetic instability in small intestinal carcinomas. Jpn J Cancer Res 1995;86:357-360.
2. Rashid A, Hamilton SR. Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine. Gastroenterology 1997;113:127-135.
3. Muneyuki T, WatanabeM, Yamanaka M, Isaji S, Kawarada Y, Yatani R. Combination analysis of genetic alterations and cell proliferation in small intestinal carcinomas. Dig Dis Sci 2000;45:2022-2028.
4. Blaker H, von Herbay A, Penzel R, Gross S, Otto HF. Genetics of adenocarcinomas of the small intestine: Frequent deletions at chromosome 18q and mutations of the SMAD4 gene. Oncogene 2002;21:158-164.
5. Wheeler JM, Warren BF, Mortensen NJ, et al. An insight into the genetic pathway of adenocarcinoma of the small intestine. Gut 2002;50:218-223.
6. Planck M, Ericson K, Piotrowska Z, Halvarsson B, Rambech E, Nilbert M. Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine. Cancer 2003;97:1551-1557.
7. Brueckl WM, Heinze E, Milsmann C, et al. Prognostic significance of microsatellite instability in curatively resected adenocarcinoma of the small intestine. Cancer Lett 2004;203:181-190.
8. Svrcek M, Jourdan F, Sebbagh N, et al. Immunohistochemical analysis of adenocarcinoma of the small intestine: A tissue microarray study. J Clin Pathol 2003;56:898-903.
9. Zhang MQ, Chen ZM, Wang HL. Immunohistochemical investigation of tumorigenic pathways in small intestinal adenocarcinoma: A comparison with colorectal adenocarcinoma. Mod Pathol 2006;19:573-580.
10. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-819.
11. Miyakura Y, Sugano K, Konishi F, et al. Extensive methylation of hMLH1 promoter region predominates in proximal colon cancer with microsatellite instability. Gastroenterology 2001;121:1300-1309.
12. Aaltonen LA, Peltomaki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-816.
13. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993;363:558-561.
14. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003;348:919-932.
15. Souza RF, Garrigue-Antar L, Lei J, et al. Alterations of transforming growth factor-beta 1 receptor type II occur in ulcerative colitis-associated carcinomas, sporadic colorectal neoplasms, and esophageal carcinomas, but not in gastric neoplasms. Hum Cell 1996;9:229-236.
16. Akiyama Y, Iwanaga R, Saitoh K, et al. Transforming growth factor beta type II receptor gene mutations in adenomas from hereditary nonpolyposis colorectal cancer. Gastroenterology 1997;112:33-39.
17. Rampino N, Yamamoto H, Ionov Y, et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997;275:967-969.
18. Duval A, Gayet J, Zhou XP, Iacopetta B, Thomas G, Hamelin R. Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability. Cancer Res 1999;59:4213-4215.
19. Mori Y, Yin J, Rashid A, et al. Instabilotyping: Comprehensive identification of frameshift mutations caused by coding region microsatellite instability. Cancer Res 2001;61:6046-6049.
20. Furlan D, Casati B, Cerutti R, et al. Genetic progression in sporadic endometrial and gastrointestinal cancers with high microsatellite instability. J Pathol 2002;197:603-609.
21. Neugut AI, Jacobson JS, Suh S, Mukherjee R, Arber N. The epidemiology of cancer of the small bowel. Cancer Epidemiol Biomarkers Prev 1998;7:243-251.
22. Arai M, Shimizu S, Imai Y, et al. Mutations of the Ki-ras, p53 and APC genes in adenocarcinomas of the human small intestine. Int J Cancer 1997;70:390-395.
23. Blaker H, Helmchen B, Bonisch A, et al. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas. Scand J Gastroenterol 2004;39:748-753.
24. Schulmann K, Brasch FE, Kunstmann E, et al. HNPCCassociated small bowel cancer: Clinical and molecular characteristics. Gastroenterology 2005;128:590-599.
25. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-5257.
26. Findeisen P, Kloor M, Merx S, et al. T25 repeat in the 3′ untranslated region of the CASP2 gene: A sensitive and specific marker for microsatellite instability in colorectal cancer. Cancer Res 2005;65:8072-8078.
27. Woerner SM, Benner A, Sutter C, et al. Pathogenesis of DNA repair-deficient cancers: A statistical meta-analysis of putative Real Common Target genes. Oncogene 2003;22:2226-2235.
28. Woerner SM, Kloor M, Mueller A, et al. Microsatellite instability of selective target genes in HNPCC-associated colon adenomas. Oncogene 2005;24:2525-2535.
29. Woerner SM, Gebert J, Yuan YP, et al. Systematic identification of genes with coding microsatellites mutated in DNA mismatch repair-deficient cancer cells. Int J Cancer 2001;93:12-19.
30. Duval A, Iacopetta B, Thorstensen L, et al. Gender difference for mismatch repair deficiency in human colorectal cancer. Gastroenterology 2001;121:1026-1027.
31. Park SJ, Rashid A, Lee JH, Kim SG, Hamilton SR, Wu TT. Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol 2003;162:815-822.
32. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004;96:261-268.
33. Bettstetter M, Dechant S, Ruemmele P, et al. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR. Clin Cancer Res 2007;13:3221-3228.
34. Deacu E, Mori Y, Sato F, et al. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes. Cancer Res 2004;64:7690-7696.
35. Woerner SM, Kloor M, Schwitalle Y, et al. The putative tumor suppressor AIM2 is frequently affected by different genetic alterations in microsatellite unstable colon cancers. Gene Chromosomes Cancer 2007;46:1080-1089.
36. Li J, Aderem A. MacMARCKS, a novel member of the MARCKS family of protein kinaseC substrates. Cell 1992;70:791-801.
37. Hartwig JH, Thelen M, Rosen A, Janmey PA, Nairn AC, Aderem A. MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin. Nature 1992;356:618-622.
38. Arbuzova A, Schmitz AA, Vergeres G. Cross-talk unfolded: MARCKS proteins. Biochem J 2002;362:1-12.
39. Yamauchi E, Nakatsu T, Matsubara M, Kato H, Taniguchi H. Crystal structure of a MARCKS peptide containing the calmodulin-binding domain in complex with Ca2+-calmodulin. Nat Struct Biol 2003;10:226-231.
40. Kim NG, Rhee H, Li LS, et al. Identification of MARCKS, FLJ11383 and TAF1B as putative novel target genes in colorectal carcinomas with microsatellite instability. Oncogene 2002;21:5081-5087.
41. Manenti S, Malecaze F, Chap H, Darbon JM. Overexpression of the myristoylated alanine-richCkinase substrate in human choroidal melanoma cells affects cell proliferation. Cancer Res 1998;58:1429-1434.
42. Brooks G, Brooks SF, Goss MW. MARCKS functions as a novel growth suppressor in cells of melanocyte origin. Carcinogenesis 1996;17:683-689.
43. Li T, Li D, Sha J, Sun P, Huang Y. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem Biophys Res Commun 2009;383:280-285.